Form
SCHEDULE 13D/A
Active or control-oriented beneficial ownership filing.
Bradley L. Radoff - 16 Apr 2025 SCHEDULE 13D/A Report for Atea Pharmaceuticals, Inc. Common Stock, $0.001 par value per share (AVIR)
- Filing manager
- Bradley L. Radoff
- Reporting owner
- Radoff Bradley Louis
- Beneficially owned shares
- 3,380,100 shares
- Large-stake signal
-
Ownership
4%Beneficial ownership of this reported class.
Shares
3,380,100 sharesShares beneficially owned as disclosed.
Event date
16 Apr 2025Date tied to the ownership event or amendment.
Accepted by SEC
17 Apr 2025EDGAR acceptance date.
How to read this large-stake filing
- Schedule 13D/G filings focus on beneficial ownership stakes, not a full portfolio.
- Compare this filing with the holder history and issuer page before treating the percentage as a current position.
- Use amendments to understand whether the disclosed stake increased, decreased, or changed reporting status.
- Class ownership
- 4%
- Symbol
- AVIR
- Shares outstanding
- 84,502,500 shares
- SEC form
- SCHEDULE 13D/A
- Accepted by SEC
- 17 Apr 2025, 12:23:57 UTC
- Event date
- 16 Apr 2025
- Prior SEC filing
- 21 Mar 2025
- Source filing
- View source filing
Ownership signal
CIK-linked ownership evidence from parsed SEC filings.
2 signals
Subject security
Names, identifiers, and filing context for this profile.
2 source fields
Source evidence
Original filing metadata and source links for verification.
5 source fields
Key filing fact
Bradley L. Radoff disclosed 4% ownership in Atea Pharmaceuticals, Inc. Common Stock, $0.001 par value per share (AVIR) on 16 Apr 2025.
Key facts
- Bradley L. Radoff filed SCHEDULE 13D/A for Atea Pharmaceuticals, Inc. Common Stock, $0.001 par value per share (AVIR).
- Disclosed ownership: 4%.
- Date of event: 16 Apr 2025.
Change
- Previous schedule filing date: 21 Mar 2025.
- Current filing was accepted on 17 Apr 2025, 12:23.
Research use
- This page turns one Schedule 13D/G filing into a quick large-stake read before the raw reporting-person rows.
- Use the linked SEC filing as the source of truth for ownership percentages, shares, and reporting-party details.
Evidence
Backed by Schedule 13D/13G
View source filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Disclosed reporting parties (10)
Names, ownership percentages, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares owned | Sole voting power | Shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Radoff Family Foundation | 0.2% | 185,000 | 0 | 185,000 | /s/ Bradley L. Radoff | Bradley L. Radoff, Director | 0001496916 |
| Radoff Bradley Louis | 4% | 3,380,100 | 3,195,100 | 185,000 | /s/ Bradley L. Radoff | Bradley L. Radoff | 0001380585 |
| JEC II Associates, LLC | 1.5% | 1,300,000 | 0 | 1,300,000 | /s/ Michael Torok | Michael Torok, Manager | 0001477326 |
| The MOS Trust | 0.1% | 100,000 | 0 | 100,000 | /s/ Michael Torok | Michael Torok, Manager of MOS PTC, LLC, its Trustee | |
| MOS PTC, LLC | 0.1% | 100,000 | 0 | 100,000 | /s/ Michael Torok | Michael Torok, Manager | |
| Torok Michael | 1.8% | 1,500,000 | 100,000 | 1,400,000 | /s/ Michael Torok | Michael Torok | 0001967237 |
| Berman Howard H. | 0% | 0 | 0 | 0 | /s/ Bradley L. Radoff | Bradley L. Radoff, attorney-in-fact for Howard H. Berman | 0001952986 |
| Nerium Partners LP | 0.1% | 54,000 | 0 | 54,000 | /s/ James P. Flynn | James P. Flynn, Managing Member of Nerium Capital LLC, its General Partner | 0001842372 |
| Nerium Capital LLC | 0.1% | 54,000 | 0 | 54,000 | /s/ James P. Flynn | James P. Flynn, Managing Member | |
| Flynn James P. | 0.1% | 54,000 | 0 | 54,000 | /s/ Bradley L. Radoff | Bradley L. Radoff, attorney-in-fact for James P. Flynn | 0001955965 |
CIK / CUSIP context first